These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30915779)

  • 1. A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus.
    Miao XY; Liu HZ; Jin MM; Sun BR; Tian H; Li J; Li N; Yan ST
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2302-2310. PubMed ID: 30915779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.
    Park SY; Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1883-1890. PubMed ID: 38175670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of low- or moderate-intensity statin and ezetimibe vs. high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study.
    Jun JE; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Eur J Prev Cardiol; 2024 Aug; 31(10):1205-1213. PubMed ID: 38408362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: A meta-analysis.
    Zhu Y; Hu H; Yang J; Yao Q; Xu H; Yu Y; Liu T; Lin S
    Bosn J Basic Med Sci; 2020 May; 20(2):169-182. PubMed ID: 31668143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe-Statin Combination Therapy.
    Nußbaumer B; Glechner A; Kaminski-Hartenthaler A; Mahlknecht P; Gartlehner G
    Dtsch Arztebl Int; 2016 Jul; 113(26):445-53. PubMed ID: 27412989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
    Suh HS; Hay JW; Johnson KA; Doctor JN
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and Safety of Statin and Ezetimibe Combination Therapy in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Lin YC; Lai TS; Wu HY; Chou YH; Chiang WC; Lin SL; Chen YM; Chu TS; Tu YK
    Clin Pharmacol Ther; 2020 Oct; 108(4):833-843. PubMed ID: 32320058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy.
    Lorenzi M; Ambegaonkar B; Baxter CA; Jansen J; Zoratti MJ; Davies G
    Clin Res Cardiol; 2019 May; 108(5):487-509. PubMed ID: 30302558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial.
    Lee YJ; Lee SH; You SC; Lee YH; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS
    Diabetes Obes Metab; 2024 Mar; 26(3):829-839. PubMed ID: 37994242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.
    Ara R; Tumur I; Pandor A; Duenas A; Williams R; Wilkinson A; Paisley S; Chilcott J
    Health Technol Assess; 2008 May; 12(21):iii, xi-xiii, 1-212. PubMed ID: 18485273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.
    Ara R; Pandor A; Tumur I; Paisley S; Duenas A; Williams R; Wilkinson A; Durrington P; Chilcott J
    Clin Ther; 2008 Aug; 30(8):1508-23. PubMed ID: 18803993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
    Miyoshi T; Nakamura K; Doi M; Ito H
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):213-9. PubMed ID: 25896669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Dyslipidemia: Epidemiology and Prevention of Cardiovascular Disease and Implications of Newer Therapies.
    Warraich HJ; Rana JS
    Curr Cardiol Rep; 2018 Oct; 20(12):125. PubMed ID: 30311078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination Moderate-Intensity Statin and Ezetimibe Therapy for Elderly Patients With Atherosclerosis.
    Lee SH; Lee YJ; Heo JH; Hur SH; Choi HH; Kim KJ; Kim JH; Park KH; Lee JH; Choi YJ; Lee SJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Kim JS
    J Am Coll Cardiol; 2023 Apr; 81(14):1339-1349. PubMed ID: 37019580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy with or without ezetimibe and the progression to diabetes.
    Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC
    J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.
    Morrone D; Weintraub WS; Toth PP; Hanson ME; Lowe RS; Lin J; Shah AK; Tershakovec AM
    Atherosclerosis; 2012 Aug; 223(2):251-61. PubMed ID: 22410123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis.
    Pintaningrum Y; Aditya Putra Pramana KA
    J Pak Med Assoc; 2024 Jun; 74(6 (Supple-6)):S23-S27. PubMed ID: 39018135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States.
    Davies GM; Vyas A; Baxter CA
    J Med Econ; 2017 Jul; 20(7):723-731. PubMed ID: 28426345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.